"At SQREEM, we believe in the power of tech for good, to uplift lives and bring social and economic progress for all. We recognize that many challenges still exist in the fight against this global pandemic, including people's hesitancy towards vaccination. The goal of this study was to develop a better understanding of the attitudes and rationales behind vaccine resistance to help healthcare professionals, regulators and policymakers find innovative ways to tackle the challenges," said Ian Chapman-Banks, CEO and co-founder of SQREEM.